🚀 VC round data is live in beta, check it out!
I-Tech Valuation Multiples
Discover revenue and EBITDA valuation multiples for I-Tech and similar public comparables like Enka de Colombia, Exel Composites, BRAIN Biotech, eXoZymes and more.
I-Tech Overview
About I-Tech
I-Tech AB is a biotechnology company. The company owns all IP and regulatory rights to the antifouling agent Selektope. Its business is to commercialize patented active substances to reduce marine fouling on hulls, gears, and other submerged structures.
Founded
2000
HQ
Employees
11
Website
Sectors
Financials (LTM)
EV
$48M
I-Tech Financials
I-Tech reported last 12-month revenue of $19M and EBITDA of $6M.
In the same LTM period, I-Tech generated $11M in gross profit, $6M in EBITDA, and $4M in net income.
Revenue (LTM)
I-Tech P&L
In the most recent fiscal year, I-Tech reported revenue of $19M and EBITDA of $5M.
I-Tech expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $19M | XXX | $19M | XXX | XXX | XXX |
| Gross Profit | $11M | XXX | $10M | XXX | XXX | XXX |
| Gross Margin | 57% | XXX | 55% | XXX | XXX | XXX |
| EBITDA | $6M | XXX | $5M | XXX | XXX | XXX |
| EBITDA Margin | 29% | XXX | 29% | XXX | XXX | XXX |
| EBIT Margin | 25% | XXX | 24% | XXX | XXX | XXX |
| Net Profit | $4M | XXX | $4M | XXX | XXX | XXX |
| Net Margin | 20% | XXX | 20% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
I-Tech Stock Performance
I-Tech has current market cap of $57M, and enterprise value of $48M.
Market Cap Evolution
I-Tech's stock price is $4.72.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $48M | $57M | 1.2% | XXX | XXX | XXX | $0.30 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialI-Tech Valuation Multiples
I-Tech trades at 2.5x EV/Revenue multiple, and 8.6x EV/EBITDA.
EV / Revenue (LTM)
I-Tech Financial Valuation Multiples
As of April 3, 2026, I-Tech has market cap of $57M and EV of $48M.
Equity research analysts estimate I-Tech's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
I-Tech has a P/E ratio of 14.7x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $57M | XXX | $57M | XXX | XXX | XXX |
| EV (current) | $48M | XXX | $48M | XXX | XXX | XXX |
| EV/Revenue | 2.5x | XXX | 2.6x | XXX | XXX | XXX |
| EV/EBITDA | 8.6x | XXX | 8.8x | XXX | XXX | XXX |
| EV/EBIT | 10.2x | XXX | 10.5x | XXX | XXX | XXX |
| EV/Gross Profit | 4.4x | XXX | 4.7x | XXX | XXX | XXX |
| P/E | 14.7x | XXX | 15.5x | XXX | XXX | XXX |
| EV/FCF | 7.7x | XXX | 6.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified I-Tech Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
I-Tech Margins & Growth Rates
I-Tech's revenue in the last 12 month grew by 11%.
I-Tech's revenue per employee in the last FY averaged $1.7M, while opex per employee averaged $0.5M for the same period.
I-Tech's rule of 40 is 42% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
I-Tech's rule of X is 59% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
I-Tech Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 11% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Margin | 29% | XXX | 29% | XXX | XXX | XXX |
| EBITDA Growth | 18% | XXX | 10% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 42% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 59% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $1.7M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.5M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 31% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
I-Tech Public Comps
See public comps and valuation multiples for other Chemicals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Enka de Colombia | XXX | XXX | XXX | XXX | XXX | XXX |
| Exel Composites | XXX | XXX | XXX | XXX | XXX | XXX |
| BRAIN Biotech | XXX | XXX | XXX | XXX | XXX | XXX |
| eXoZymes | XXX | XXX | XXX | XXX | XXX | XXX |
| Loop Industries | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
I-Tech M&A Activity
I-Tech acquired XXX companies to date.
Last acquisition by I-Tech was on XXXXXXXX, XXXXX. I-Tech acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by I-Tech
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialI-Tech Investment Activity
I-Tech invested in XXX companies to date.
I-Tech made its latest investment on XXXXXXXX, XXXXX. I-Tech invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by I-Tech
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout I-Tech
| When was I-Tech founded? | I-Tech was founded in 2000. |
| Where is I-Tech headquartered? | I-Tech is headquartered in Sweden. |
| How many employees does I-Tech have? | As of today, I-Tech has over 11 employees. |
| Is I-Tech publicly listed? | Yes, I-Tech is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of I-Tech? | I-Tech trades under ITECH ticker. |
| When did I-Tech go public? | I-Tech went public in 2018. |
| Who are competitors of I-Tech? | I-Tech main competitors are Enka de Colombia, Exel Composites, BRAIN Biotech, eXoZymes. |
| What is the current market cap of I-Tech? | I-Tech's current market cap is $57M. |
| What is the current revenue of I-Tech? | I-Tech's last 12 months revenue is $19M. |
| What is the current revenue growth of I-Tech? | I-Tech revenue growth (NTM/LTM) is 11%. |
| What is the current EV/Revenue multiple of I-Tech? | Current revenue multiple of I-Tech is 2.5x. |
| Is I-Tech profitable? | Yes, I-Tech is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of I-Tech? | I-Tech's last 12 months EBITDA is $6M. |
| What is I-Tech's EBITDA margin? | I-Tech's last 12 months EBITDA margin is 29%. |
| What is the current EV/EBITDA multiple of I-Tech? | Current EBITDA multiple of I-Tech is 8.6x. |
| What is the current FCF of I-Tech? | I-Tech's last 12 months FCF is $6M. |
| What is I-Tech's FCF margin? | I-Tech's last 12 months FCF margin is 33%. |
| What is the current EV/FCF multiple of I-Tech? | Current FCF multiple of I-Tech is 7.7x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.